Simple enzyme drops could help tiny babies tolerate feeds
NCT ID NCT07088302
First seen Jan 17, 2026 · Last updated Jun 23, 2026 · Updated 18 times
Summary
This study tests whether giving lactase enzyme drops with formula milk can prevent feeding intolerance in very premature infants (≤32 weeks). 120 babies will receive either lactase or placebo for 14 days. Researchers will track vomiting, stomach swelling, and leftover milk in the stomach to see if the enzyme helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Marwa Mohamed Farag
RECRUITINGAlexandria, 0325, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lactase enzyme drops
What this could lead to
If it works, this could offer a simple way to prevent feeding problems in premature babies, reducing time in the NICU.
What could go wrong
This is a small, early-stage trial with only 120 infants. The effect may be small or not work at all, and results may not apply to all preterm babies.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.